Full page update
We updated this page and it's database with the newest meta-analyses.
Gymnema sylvestre (GS) is a plant in the Gymnema genus of the Asclepiadaceae family. It has been used in ayurvedic medicine and homeopathy to treat multiple conditions, including arthritis, asthma, and snake bites. Today, it is most commonly used as a supplement to help regulate blood sugar levels.
Gymnema Sylvestre is most often used for
Last Updated:January 11, 2024
Gymnema sylvestre is a woody plant native to Southeast Asia and India; it is traditionally used in Ayurvedic medicine for various conditions, including blood sugar reduction. Its popularity has increased as a supplement for managing diabetes, insulin resistance, and metabolic syndrome.
Gymnema sylvestre may improve glycemic control and blood lipids and potentially reduce the risk of cardiovascular disease. Some evidence also suggests that it may help with stomach ulcers.
The main drawbacks of Gymnema sylvestre include mild side effects (such as diarrhea and headaches), potential hypoglycemia, and limited safety data, particularly in humans. Additionally, variations in plant preparations and possible interactions with medications, especially those for diabetes, complicate its safety evaluation.
Gymnema sylvestre reduces blood glucose through mechanisms such as inhibiting intestinal glucose absorption and stimulating insulin production in the pancreas. It may improve blood lipids by increasing pancreatic lipase levels and fat excretion, and its anti-inflammatory and antiulcer properties are associated with compounds that inhibit gastric acid secretion and regulate gastric emptying.
Dosages used in research range from 400 mg per day up to 10 grams per day. The most frequent recommendation from manufacturers of GS supplements is to take a 100 mg tablet 3–4 times daily. While this dosage is likely to be safe for most people, an evidence-based dosage has not yet been established.[1]
Unlock the full potential of Examine
Full page update
We updated this page and it's database with the newest meta-analyses.